Atara Biotherapeutics, Inc. (36) | Business Finance (8)
Browse by Subcategory
Recent Contracts
-
Asset Purchase Agreement, dated as of January 26, 2022, by and between Atara Biotherapeutics, Inc., FUJIFILM Diosynth Biotechnologies California, Inc., and for certain limited...
(Filed With SEC on April 4, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on December 9, 2020)
-
Underwriting Agreement, dated as of December 8, 2020, by and among Atara Biotherapeutics, Inc., Citigroup Global Markets Inc., Evercore Group L.L.C. and Mizuho Securities USA LLC
(Filed With SEC on December 9, 2020)
-
Form of Restricted Stock Unit Agreement and Restricted Stock Unit Grant Notice under the 2018 Inducement Plan
(Filed With SEC on November 7, 2019)
-
Underwriting Agreement, dated as of May 26, 2020, by and among Atara Biotherapeutics, Inc., Citigroup Global Markets Inc., Cowen and Company, LLC and Evercore Group L.L.C
(Filed With SEC on May 28, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on May 28, 2020)
-
Underwriting Agreement, dated as of July 18, 2019, by and among Atara Biotherapeutics, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC and Cowen and Company, LLC
(Filed With SEC on July 22, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on July 22, 2019)